Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01211444 · ClinicalTrials.gov registry record · Phase 2
US Clinical Study of the Apnex Medical Hypoglossal Nerve Stimulation (HGNS) System to Treat Obstructive Sleep Apnea
A Phase 2 study of Obstructive Sleep Apnea, sponsored by Apnex Medical.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
- 4
- Study locations
NCT01211444: Completed Phase 2 study of Obstructive Sleep Apnea, sponsored by Apnex Medical.
NCT01211444 is a Phase 2 study of Obstructive Sleep Apnea that has completed, run by Apnex Medical. The registered enrollment target is 20 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (91% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01211444, a Phase 2 study of Obstructive Sleep Apnea, has completed, sponsored by Apnex Medical.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
- 4
- Study locations
Study Summary
The overall goal of the study is to evaluate the safety, efficacy and therapy settings of the Hypoglossal Nerve Stimulation (HGNS) System for stimulating the hypoglossal nerve to help maintain airway opening in subjects with Obstructive Sleep Apnea (OSA).
Conditions Studied
Interventions
- DEVICE HGNS Treatment
Study Locations (4)
California
- University of California San Francisco - San Francisco
Indiana
- Saint Vincent Hospital - Indianapolis
Minnesota
- University of Minnesota - Minneapolis
New York
- Clinilabs, Inc. - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-07 |
| Est. Completion | 2013-08 |
| Phase | Phase 2 |
What the finished NCT01211444 record still lists
NCT01211444 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which HGNS Treatment is the first listed.
NCT01211444 reports a single indexed study location in California, Indiana, Minnesota.
Frequently Asked Questions
What is clinical trial NCT01211444 about?
NCT01211444 is a clinical study titled "US Clinical Study of the Apnex Medical Hypoglossal Nerve Stimulation (HGNS) System to Treat Obstructive Sleep Apnea". The overall goal of the study is to evaluate the safety, efficacy and therapy settings of the Hypoglossal Nerve Stimulation (HGNS) System for stimulating the hypoglossal nerve to help maintain airway opening in subjects with Obstructive Sleep Apnea (OSA).
What is the current status of trial NCT01211444?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2010-07. Estimated completion is 2013-08.
What conditions does trial NCT01211444 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea.
What interventions are being tested in trial NCT01211444?
The interventions under investigation include: HGNS Treatment (DEVICE).
Who is sponsoring clinical trial NCT01211444?
This trial is sponsored by Apnex Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01211444 being conducted?
This trial has 4 study locations across California, Indiana, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01211444's enrollment target sits among peer trials
20 140th of 155 higher than 13 of 155 other Obstructive Sleep Apnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obstructive Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient-centered and Neurocognitive Outcomes with Acetazolamide for Sleep Apnea
RECRUITING · Phase 2
-
The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)
RECRUITING · Phase 2
-
Do Endotypes Predict Response and Sequelae in OSA Patients
RECRUITING · Phase 2
-
Medications for Obstructive Sleep Apnea to Improve Cognition in Children With Down Syndrome
RECRUITING · Phase 2
-
Down Syndrome Obstructive Sleep Apnea
RECRUITING · Phase 2
-
Dexmedetomidine Versus Propofol Sedation for Drug-Induced Sleep Endoscopy in Pediatric Obstructive Sleep Apnea
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia